Примери за използване на Secondary endpoint на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Secondary endpoint.
ASAS 40 was a secondary endpoint.
A key secondary endpoint was the restoration of haemostasis.
Overall survival(OS) was the key secondary endpoint.
Other secondary endpoint.
Exercise capacity was evaluated as a secondary endpoint.
Key Secondary Endpoint.
The CGI-S was also assessed in trials 3 and 5 as secondary endpoint.
Efficacy was a secondary endpoint in this study.
The primary endpoint was PFS; OS was the key secondary endpoint.
Body weight was a secondary endpoint in the clinical development trials.
Safety was the primary endpoint andefficacy was a secondary endpoint.
An additional secondary endpoint included PFS of Combo 450 compared with Enco 300.
Serum bactericidal activity was also measured using hSBA as a secondary endpoint.
The secondary endpoint was complete remission rate that was assessed by independent expert review.
P< 0.001 for comparison between guselkumab andplacebo for the major secondary endpoint.
An effect was seen on the critical secondary endpoint of spontaneous pain visual analogue scale(VAS).
The primary endpoint of the study was OS with a key secondary endpoint of PFS.
A key secondary endpoint was the incidence of proven/probable IFIs at 100 days post-randomisation.
Complete haematological response(CHR)in CP patients was evaluated as a secondary endpoint.
An effect was claimed based on analysis of the secondary endpoint time to definitive deterioration in HRQoL.
The analyses of the secondary endpoint health-related quality of life(HRQoL) did not show an advantage of addition of bevacizumab to standard treatment.
Efficacy of Prevenar against AOM was assessed as a secondary endpoint in the Kaiser Permanente trial.
The secondary endpoint, PFS, demonstrated a 29% risk reduction of progression or death and a 22 month improvement in median PFS(35.5 months for TPF and 13.1 for PF).
The primary endpoint was time to disease progression and the secondary endpoint was overall survival.
Analysis of total mortality as a secondary endpoint did not show any significant difference between clopidogrel(5.8%) and ASA(6.0%).
Statistically significant improvements were observed for the primary endpoint of PFS and secondary endpoint of overall response rate(ORR).
Results of the secondary endpoint OS were not consistent with the primary endpoint PFS, with a trend observed favouring the everolimus alone arm.
Key findings from SMART by inhaled steroid use at baseline: secondary endpoints Number of secondary endpoint.
The secondary endpoint of progression free survival was 4.8 and 4.3 months, respectively(stratified HR 0.95; 95% CI: 0.87-1.04), ruling out the pre-defined 15% risk increase.